ALDX 8-K 2026-09-29
Aldeyra Therapeutics, Inc. (ALDX) 8-K dated 2026-09-29 — accession 0001193125-26-405954.
Aldeyra Therapeutics, Inc. (ALDX) is a biotechnology company listed on US.
Aldeyra Therapeutics, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-405954.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for ALDX is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The ALDX SEC hub lists recent forms. The stock page is the research view.